A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents

Condition:   Healthy Interventions:   Drug: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC;   Drug: Darunavir;   Drug: Emtricitabine/Tenofovir Alafenamide;   Drug: Cobicistat Sponsor:   Janssen Research & Development, LLC Not yet recruiting

Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials